Table 1.
Screened substances
| Substance | Abbreviation | Type | Slices | ROIs | n eff |
|---|---|---|---|---|---|
| Serotonin (5-hydroxytryptamine) | 5-HT | Amine | f3/m5 | f109/m76 | 10.7 |
| Adrenocorticotropic hormone | ACTH | Peptide | f2/m2 | f106/m128 | 6.03 |
| Adenosine | Ade | Nuc. A. | f3/m3 | f59/m124 | 7.90 |
| Adiponectin | Adiponectin | Peptide | f2/m2 | f95/m128 | 7.36 |
| Agouti-related peptide | AgRP | Peptide | f2/m2 | f57/m123 | 6.40 |
| Angiotensin II | AngII | Peptide | f3/m3 | f102/m143 | 10.5 |
| Adenosine triphosphate | ATP | Nuc. A. | f3/m3 | f68/m125 | 37.2 |
| Arginine vasopressin | AVP | Peptide | f2/m4 | f57/m64 | 16.1 |
| Cocaine-and amphetamine-related transcript | CART | Peptide | f2/m2 | f35/m73 | 24.0 |
| Carbachol | CCh | Choline | f3/m3 | f178/m126 | 8.87 |
| Corticotropin releasing factor | CRF | Peptide | f2/m4 | f75/m64 | 9.08 |
| (Control) | (Control) | n.a. | f24/m22 | f892/m829 | 65.4 |
| Dopamine | DA | Amine | f3/m3 | f122/m130 | 6.69 |
| [d-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin | DAMGO | Peptide | f5/m3 | f103/m124 | 11.0 |
| Dynorphin | Dyn | Peptide | f2/m2 | f75/m70 | 6.90 |
| Endothelin-3 | EDT3 | Peptide | f2/m2 | f98/m128 | 4.78 |
| γ-Aminobutyric acid | GABA | Ami. A. | f24/m22 | f892/m829 | 53.5 |
| Galanin | Galanin | Peptide | f3/m3 | f69/m129 | 8.15 |
| Growth hormone | GH | Peptide | f2/m2 | f106/m128 | 7.60 |
| Ghrelin | Ghrelin | Peptide | f3/m2 | f69/m90 | 13.3 |
| Glucagon-like peptide-1 | GLP-1 | Peptide | f3/m4 | f129/m121 | 11.4 |
| Glutamate | Glu | Ami. A. | f24/m22 | f892/m829 | 59.8 |
| Glycine | Gly | Ami. A. | f3/m3 | f128/m73 | 8.41 |
| Gastrin-releasing peptide | GRP | Peptide | f3/m3 | f118/m67 | 10.6 |
| Histamine | HA | Amine | f3/m3 | f93/m116 | 9.04 |
| Interleukin-1β | IL-1β | Peptide | f2/m2 | f96/m103 | 5.87 |
| Insulin | Insulin | Peptide | f3/m2 | f127/m110 | 6.30 |
| Leptin | Leptin | Peptide | f2/m2 | f95/m128 | 7.81 |
| Melanin-concentrating hormone | MCH | Peptide | f2/m4 | f85/m64 | 24.5 |
| Melatonin | MLTN | Amine | f3/m3 | f111/m121 | 13.4 |
| Noradrenaline | NA | Amine | f3/m3 | f75/m98 | 11.4 |
| Neurotensin | NTS | Peptide | f3/m3 | f76/m125 | 14.3 |
| Neuromedin U | NMU | Peptide | f3/m3 | f136/m123 | 6.73 |
| Nociceptin | Nociceptin | Peptide | f4/m3 | f53/m109 | 9.15 |
| Neuropeptide S | NPS | Peptide | f2/m4 | f69/m64 | 14.6 |
| Neuropeptide W | NPW | Peptide | f2/m2 | f69/m35 | 10.1 |
| Neuropeptide Y | NPY | Peptide | f3/m4 | f109/m64 | 9.97 |
| Obestatin | Obestatin | Peptide | f2/m2 | f73/m117 | 4.27 |
| Orexin-A | ORX-A | Peptide | f3/m3 | f109/m124 | 8.66 |
| Oxytocin | OXT | Peptide | f2/m5 | f92/m76 | 22.5 |
| Pituitary adenylate cyclase-activating polypeptide | PACAP27 | Peptide | f2/m2 | f84/m35 | 5.51 |
| Prostaglandin D2 | PGD2 | Lipid | f3/m4 | f69/m169 | 14.7 |
| Prostaglandin E2 | PGE2 | Lipid | f5/m3 | f77/m125 | 11.2 |
| Prokineticin-2 | PK2 | Peptide | f2/m2 | f75/m121 | 7.37 |
| Pancreatic polypeptide | PP | Peptide | f3/m3 | f102/m141 | 7.84 |
| Prolactin-releasing peptide | PrRP | Peptide | f2/m2 | f96/m121 | 7.45 |
| Peptide tyrosine tyrosine | PYY | Peptide | f3/m3 | f114/m138 | 17.3 |
| Pyroglutamylated RF amide peptide | QRFP | Peptide | f2/m3 | f93/m77 | 6.11 |
| Secretin | Secretin | Peptide | f2/m2 | f18/m94 | 7.36 |
| Somatostatin | SST | Peptide | f3/m3 | f112/m116 | 6.92 |
| Thyrotropin-releasing hormone | TRH | Peptide | f3/m3 | f122/m112 | 7.86 |
| Urocortin-3 | UCN | Peptide | f2/m2 | f81/m35 | 51.0 |
| Vasoactive intestinal peptide | VIP | Peptide | f2/m2 | f61/m35 | 6.60 |
| Alpha-melanocyte-stimulating hormone | α-MSH | Peptide | f2/m2 | f35/m90 | 4.80 |
Substances used for screening are shown in the table listed by substance (1st column), abbreviation (2nd column), type (3rd column), n of slices (4th column) from female (f) and male (m) animals, n of ROIs (5th column) from female (f) and male (m) slices, and the effective sample size (neff, 6th column). Ami. A., amino acid; Nuc. A., nucleic acid; n.a., not applicable.